Related Experiment Video
Updated: May 17, 2026
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis
Lei Wang1, Jeffrey Ho, Carlotta Glackin
1Department of Cell Biology and Neuroscience, University of California, Riverside, Riverside, CA 92521.
Abstract:
Pomegranate juice (PJ) is a natural product that inhibits prostate cancer progression. A clinical trial on patients with recurrent prostate cancer resulted in none of the patients progressing to a metastatic stage during the period of the trial. We have previously found that, in addition to causing cell death of hormone-refractory prostate cancer cells, PJ also markedly increases adhesion and decreases migration of the cells that do not die. However, because PJ is a very complex mixture of components and is found in many different formulations, it is important to identify specific components that are effective in inhibiting growth and metastasis. Here, we show that the PJ components luteolin, ellagic acid, and punicic acid together inhibit growth of hormone-dependent and hormone-refractory prostate cancer cells and inhibit their migration and their chemotaxis toward stromal cell-derived factor 1α (SDF1α), a chemokine that is important in prostate cancer metastasis to the bone. These components also increase the expression of cell adhesion genes and decrease expression of genes involved in cell cycle control and cell migration. Furthermore, they increase several well-known tumor-suppression microRNAs (miRNAs), decrease several oncogenic miRNAs, and inhibit the chemokines receptor type 4 (CXCR4)/SDF1α chemotaxis axis. Our results suggest that these components may be more effective in inhibiting prostate cancer growth and metastasis than simply drinking the juice. Chemical modification of these components could further enhance their bioavailability and efficacy of treatment. Moreover, because the mechanisms of metastasis are similar for most cancers, these PJ components may also be effective in the treatment of metastasis of other cancers.
Insights
Specific pomegranate juice components, luteolin, ellagic acid, and punicic acid, inhibit prostate cancer cell growth and metastasis. These compounds may offer a more effective treatment than pomegranate juice alone for cancer treatment.
Area of Science:
- Oncology
- Natural Products Chemistry
- Molecular Biology
Background:
- Pomegranate juice (PJ) shows promise in inhibiting prostate cancer progression and metastasis.
- Identifying specific active components in PJ is crucial for targeted cancer therapy.
- Previous research indicated PJ increases prostate cancer cell adhesion and reduces migration.
Purpose of the Study:
- To identify and evaluate specific pomegranate juice components for their efficacy against prostate cancer growth and metastasis.
- To investigate the molecular mechanisms underlying the anti-cancer effects of these components.
Main Methods:
- Assessed the effects of luteolin, ellagic acid, and punicic acid on hormone-dependent and hormone-refractory prostate cancer cell lines.
- Measured inhibition of cell growth, migration, and chemotaxis toward SDF1α.
- Analyzed changes in gene expression related to cell adhesion, cell cycle, and migration.
- Quantified alterations in tumor-suppressor and oncogenic microRNAs (miRNAs).
- Investigated the impact on the CXCR4/SDF1α signaling pathway.
Main Results:
- Luteolin, ellagic acid, and punicic acid synergistically inhibited prostate cancer cell growth.
- These components reduced cell migration and chemotaxis towards SDF1α.
- Increased expression of cell adhesion genes and decreased expression of cell cycle and migration genes were observed.
- Elevated levels of tumor-suppressive miRNAs and decreased levels of oncogenic miRNAs were detected.
- Inhibition of the CXCR4/SDF1α chemotaxis axis was confirmed.
Conclusions:
- The identified PJ components (luteolin, ellagic acid, punicic acid) demonstrate significant potential in inhibiting prostate cancer growth and metastasis.
- These compounds may be more effective than whole PJ due to targeted action and potential for enhanced bioavailability through chemical modification.
- The findings suggest broader applications for these compounds in treating metastasis across various cancer types.
